Journal article
Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
- Abstract:
-
Regulatory T cells (T(reg)) are currently being tested in clinical trials as a potential therapy in cell and solid organ transplantation. The immunosuppressive drug rapamycin has been shown to preferentially promote T(reg) expansion. Here, we hypothesized that adjunctive rapamycin therapy might potentiate the ability of ex vivo expanded human T(reg) to inhibit vascular allograft rejection in a humanized mouse model of arterial transplantation. We studied the influence of combined treatment wi...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
- Volume:
- 12
- Issue:
- 8
- Pages:
- 2008-2016
- Publication date:
- 2012-08-01
- DOI:
- EISSN:
-
1600-6143
- ISSN:
-
1600-6135
- Source identifiers:
-
348924
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:348924
- UUID:
-
uuid:894bcc7a-a797-43d9-9fc9-078ecfb91758
- Local pid:
- pubs:348924
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record